Emily Kopp, Web Producer at Kaiser Health News, most recently worked as a freelance reporter. She has previously worked at Politico and AIS Health. Before that, she interned with the Center for Responsive Politics.
Emily Kopp
From this contributor
Nonprofit with ties to pharma launches campaign against drug imports
Both the Pharmaceutical Research and Manufacturers of America and the nonprofit group have gone to great lengths to show that drugmakers are not driving what they describe as a “grass-roots” effort to fight imports.
Nonprofit with ties to pharma launches campaign against drug imports
Senators want answers about reported probe of U.S. health secretary
Nine U.S. senators are pushing the U.S. Attorney General to reveal what he knows about a reported investigation into Tom Price’s stock trades that a top federal prosecutor might have begun before being fired by the Trump administration.
Senators want answers about reported probe of U.S. health secretary
Most patient advocacy groups accept funding from pharma
At least 83 percent of the United States' largest patient advocacy groups take contributions from the drug industry, and not all of them are transparent about it.
Most patient advocacy groups accept funding from pharma
Explore more from The Transmitter
Commentary: Citation graphs may underestimate neuroscience’s influence on AI
An alternative, albeit less quantitative, way to trace this history is through the people who carried ideas between the fields.
Commentary: Citation graphs may underestimate neuroscience’s influence on AI
An alternative, albeit less quantitative, way to trace this history is through the people who carried ideas between the fields.
Commentary: The rising absolute number of neuro-inspired AI papers represents a substantial footprint
Many of the design choices present in the current generation of artificial-intelligence tools parallel purported properties of the brain.
Commentary: The rising absolute number of neuro-inspired AI papers represents a substantial footprint
Many of the design choices present in the current generation of artificial-intelligence tools parallel purported properties of the brain.
Examining the bridge between neuroscience and AI
A citation analysis reveals that the connection between the two fields is real and gaining momentum. But it’s also narrow and tool-heavy; we need to find ways to widen it.
Examining the bridge between neuroscience and AI
A citation analysis reveals that the connection between the two fields is real and gaining momentum. But it’s also narrow and tool-heavy; we need to find ways to widen it.